by Editorial Team | 17 Nov, 2023 | NEWS, TheraPPI
November 17, 2023 – Lyon, France The Fondation Genevoise pour l’Innovation Technologique (“FONGIT”) has granted a FIF seed loan of CHF100 000 to TheraPPI Bioscience which is currently being registered in the Canton of Geneva (Switzerland) for their innovative...
by Editorial Team | 9 Nov, 2023 | NEWS, TheraPPI
TheraPPI Bioscience SAS is proud to announce that it has been awarded the French Tech Seed label, a recognition reserved for DeepTech startups less than three years old. This distinction acknowledges TheraPPI’s remarkable technological innovation, astute...
by Luc A. Otten | 18 Oct, 2023 | Mablink, NEWS
The pending acquisition reflects the potential of Mablink’s existing pipeline and proprietary PSARLink™ technology for development of additional drug conjugates. October 18, 2023 – Lyon, France Mablink Bioscience (“Mablink”), a pre-clinical biotechnology company...
by Editorial Team | 30 Aug, 2023 | Netris, NEWS
August 30th, 2023 LYON, France — Netris Pharma, a clinical stage biopharmaceutical company developing first-in-class anticancer drugs, today announced data showing that its lead compound, NP137, is effective in reducing tumor growth and inhibiting tumor...
by Luc A. Otten | 15 Jun, 2023 | Mablink, NEWS
June 15, 2023 – Lyon, France Mablink Bioscience (“Mablink”), a biotechnology company dedicated to advancing cancer therapy with next-generation antibody-drug conjugates (ADCs),today announced the appointment of Dr. Pejvack Motlagh, M.D., as Chief Medical...